Masauji N - Search Results

1

Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation.

Nagashima T, Sato F, Chuma T, Mano Y, Sasaki I, Mori M, Higa T, Masauji N, Kasai M, Orba Y, Shinohara T, Nagashima K. Nagashima T, et al. Among authors: masauji n. Neuropathology. 2002 Mar;22(1):1-8. Neuropathology. 2002. PMID: 12030409

2

Allogeneic bone marrow transplantation as a therapeutic modality for hematological disorders: a report based on 39 cases.

Naohara T, Hashino S, Masauji N, Matsuura A, Ohizumi H, Kobayashi N, Morii K, Kiyama Y, Saitoh M, Higa T, et al. Naohara T, et al. Among authors: masauji n. Hokkaido Igaku Zasshi. 1994 Sep;69(5):1199-207. Hokkaido Igaku Zasshi. 1994. PMID: 7868058 Clinical Trial.

3

Molecular analysis of T-cell repertoire in patients with graft-versus-host disease after allogeneic stem cell transplantation.

Tsutsumi Y, Tanaka J, Miura Y, Toubai T, Kato N, Fujisaw F, Toyoshima N, Ota S, Mori A, Yonezumi M, Chiba K, Kondo T, Hasino S, Kobayasi R, Masauji N, Kasai M, Asaka M, Imamura M. Tsutsumi Y, et al. Among authors: masauji n. Leuk Lymphoma. 2004 Mar;45(3):481-8. doi: 10.1080/10428190310001609898. Leuk Lymphoma. 2004. PMID: 15160909

4

Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.

Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S, Sakamaki H, Kouzai Y, Kasai M, Fukuda T, Azuma H, Takanashi M, Okamoto S, Tsuchida M, Kawa K, Morishima Y, Kodera Y, Kato S; Japan Cord Blood Bank Network. Atsuta Y, et al. Blood. 2009 Feb 19;113(8):1631-8. doi: 10.1182/blood-2008-03-147041. Epub 2008 Dec 22. Blood. 2009. PMID: 19104080 Free article. Clinical Trial.

5

[Detection of point mutation of K-ras gene codon 12 in biliary tract and ampullary carcinoma by modified two-step polymerase chain reaction].

Watanabe M, Tanaka J, Masauji N, Matsuura A, Kiyama Y, Morii K, Naohara T, Saitoh M, Higa T, Kasai M, et al. Watanabe M, et al. Among authors: masauji n. Nihon Shokakibyo Gakkai Zasshi. 1993 Apr;90(4):789-94. Nihon Shokakibyo Gakkai Zasshi. 1993. PMID: 8492470 Japanese.

6

Effects of the mean daily doses of imatinib during the first year on survival of patients with chronic myeloid leukemia in Japan: a study of the Hokkaido Hematology Study Group.

Sugita J, Tanaka J, Kurosawa M, Fukuhara T, Hashino S, Torimoto E, Koizumi K, Masauji N, Nishimura S, Koda K, Imamura M, Kasai M; Hokkaido Hematology Study Group. Sugita J, et al. Among authors: masauji n. Eur J Haematol. 2008 Feb;80(2):160-3. doi: 10.1111/j.1600-0609.2007.00982.x. Epub 2007 Nov 17. Eur J Haematol. 2008. PMID: 18028432

7

Early recovery of host-derived hematopoiesis in marrow transplant recipients conditioned with high-dose busulfan and cyclophosphamide.

Yamaguchi M, Nakao S, Ueda M, Takamatsu H, Tamaru Y, Shiobara S, Masauji N, Matsue K, Matsuda T. Yamaguchi M, et al. Among authors: masauji n. Bone Marrow Transplant. 1995 May;15(5):787-9. Bone Marrow Transplant. 1995. PMID: 7670408

8

Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.

Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T, Kaneda M, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Masauji N, Matsunaga T, Mori A, Mukai M, Nishio M, Noto S, Ota S, Sakai H, Suzuki N, Takahashi T, Tanaka J, Torimoto Y, Yoshida M, Fukuhara T. Onozawa M, et al. Among authors: masauji n. Biol Blood Marrow Transplant. 2009 Jun;15(6):724-9. doi: 10.1016/j.bbmt.2009.03.003. Biol Blood Marrow Transplant. 2009. PMID: 19450757 Free article.

9

[Second marrow transplantation following high dose busulfan, etoposide, and Ara-C after testicular relapse in a patient with AML].

Matsue K, Tohi T, Masauji N, Tsukuda K. Matsue K, et al. Among authors: masauji n. Rinsho Ketsueki. 1992 Mar;33(3):338-42. Rinsho Ketsueki. 1992. PMID: 1578638 Japanese.

10

Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.

Tauchi T, Kizaki M, Okamoto S, Tanaka H, Tanimoto M, Inokuchi K, Murayama T, Saburi Y, Hino M, Tsudo M, Shimomura T, Isobe Y, Oshimi K, Dan K, Ohyashiki K, Ikeda Y; TARGET Investigators. Tauchi T, et al. Leuk Res. 2011 May;35(5):585-90. doi: 10.1016/j.leukres.2010.10.027. Epub 2010 Dec 10. Leuk Res. 2011. PMID: 21145591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters